206 related articles for article (PubMed ID: 17525899)
41. Infections in pediatric patients with hematologic malignancies.
Bailey LC; Reilly AF; Rheingold SR
Semin Hematol; 2009 Jul; 46(3):313-24. PubMed ID: 19549582
[TBL] [Abstract][Full Text] [Related]
42. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
43. Venous thromboembolism incidence in hematologic malignancies.
Kekre N; Connors JM
Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
[TBL] [Abstract][Full Text] [Related]
44. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.
Imberti D; Agnelli G; Ageno W; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
Haematologica; 2008 Feb; 93(2):273-8. PubMed ID: 18223291
[TBL] [Abstract][Full Text] [Related]
45. Bleeding complications in patients with hematologic malignancies.
Franchini M; Frattini F; Crestani S; Bonfanti C
Semin Thromb Hemost; 2013 Feb; 39(1):94-100. PubMed ID: 23247655
[TBL] [Abstract][Full Text] [Related]
46. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
47. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
Rickles FR; Falanga A; Montesinos P; Sanz MA; Brenner B; Barbui T
Thromb Res; 2007; 120 Suppl 2():S99-106. PubMed ID: 18023721
[TBL] [Abstract][Full Text] [Related]
48. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
49. Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors.
Saracco P; Parodi E; Fabris C; Cecinati V; Molinari AC; Giordano P
Thromb Res; 2009 Apr; 123(6):805-9. PubMed ID: 19167028
[TBL] [Abstract][Full Text] [Related]
50. Local thrombolysis: a newer approach to treating inflammatory bowel disease-related thromboembolism.
Tabibian JH; Roth BE
J Clin Gastroenterol; 2009; 43(5):391-8. PubMed ID: 19247203
[TBL] [Abstract][Full Text] [Related]
51. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
52. [Pediatric venous thromboembolism: review of the literature and news].
Demulder A
Rev Med Brux; 2005; 26 Spec no():Sp27-30. PubMed ID: 16454230
[TBL] [Abstract][Full Text] [Related]
53. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.
Khorana AA; Francis CW; Culakova E; Kuderer NM; Lyman GH
Cancer; 2007 Nov; 110(10):2339-46. PubMed ID: 17918266
[TBL] [Abstract][Full Text] [Related]
54. Thrombosis in pediatric cancer: identifying the risk factors to improve care.
Athale U
Expert Rev Hematol; 2013 Oct; 6(5):599-609. PubMed ID: 24125523
[TBL] [Abstract][Full Text] [Related]
55. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
Falanga A; Barbui T; Rickles FR
Semin Thromb Hemost; 2008 Mar; 34(2):204-10. PubMed ID: 18645927
[TBL] [Abstract][Full Text] [Related]
56. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
Pulte D; Gondos A; Brenner H
Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
[TBL] [Abstract][Full Text] [Related]
57. Thromboembolic complications in malignant haematological disorders.
Castelli R; Ferrari B; Cortelezzi A; Guariglia A
Curr Vasc Pharmacol; 2010 Jul; 8(4):482-94. PubMed ID: 19485900
[TBL] [Abstract][Full Text] [Related]
58. Drug-related thrombosis in hematologic malignancies.
Nadir Y; Hoffman R; Brenner B
Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
[TBL] [Abstract][Full Text] [Related]
59. [Thrombophilic states: their relevance in prevention and treatment of venous thromboembolism].
Poul H; Kessler P
Vnitr Lek; 2009 Mar; 55(3):242-52. PubMed ID: 19378855
[TBL] [Abstract][Full Text] [Related]
60. Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service.
Kuhle S; Massicotte P; Chan A; Adams M; Abdolell M; de Veber G; Mitchell L
Thromb Haemost; 2004 Oct; 92(4):722-8. PubMed ID: 15467901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
